Proteins with complex architecture as potential targets for drug design: A case study of Mycobacterium tuberculosis

PLoS Computational Biology

Volumn 7, Issue 7, 2011, Pages

  Mészáros, Bálint ^a   Tóth, Judit ^a   Vértessy, Beáta G ^a,b   Dosztányi, Zsuzsanna ^a   Simon, István ^a  

^a INSTITUTE OF ENZYMOLOGY   (Hungary)

^b BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; GENES; NETWORK ARCHITECTURE; TUBES (COMPONENTS);

CASE-STUDIES; COMPLEX ARCHITECTURES; COMPLEX DOMAINS; DRUG DESIGN; DRUG TARGETS; M. TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; POTENTIAL TARGETS; SPECIES SPECIFICS; TARGETS SELECTION;

PROTEINS;

BACTERIAL PROTEIN; PROTEIN PE; PROTEIN PKN; PROTEIN PPE; PROTEOME; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL PROTOCOL; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DESIGN; DRUG TARGETING; GENE IDENTIFICATION; HOST PATHOGEN INTERACTION; MATHEMATICAL COMPUTING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; SEQUENCE ANALYSIS; SPECIES DIFFERENCE;

CORYNEBACTERINEAE; EUKARYOTA; HOMO SAPIENS; MYCOBACTERIUM TUBERCULOSIS; PROKARYOTA;

EID: 84856026736     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002118     Document Type: Article

References (101)

1. Global tuberculosis control: key findings from the December 2009 WHO report. Wkly Epidemiol Rec 85: 69-80.
2. Onozaki I, Raviglione M, (2010) Stopping tuberculosis in the 21st century: goals and strategies. Respirology 15: 32-43.
3. Pieters J, (2008) Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 3: 399-407.
4. Iwai K, Maeda S, Murase Y, (2010) [Archaeology of tubercle bacilli and tuberculosis]. Kekkaku 85: 465-475.
5. Boshoff HI, Reed MB, Barry 3rd CE, Mizrahi V, (2003) DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 113: 183-193.
6. Borrell S, Gagneux S, (2009) Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13: 1456-1466.
7. Suchindran S, Brouwer ES, Van Rie A, (2009) Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS One 4: e5561.
8. Sacks LV, Behrman RE, (2008) Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective. Tuberculosis (Edinb) 88 (Suppl 1): S93-100.
9. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
10. Cubillos-Ruiz A, Morales J, Zambrano MM, (2008) Analysis of the genetic variation in Mycobacterium tuberculosis strains by multiple genome alignments. BMC Res Notes 1: 110.
11. Vishnoi A, Srivastava A, Roy R, Bhattacharya A, (2008) MGDD: Mycobacterium tuberculosis genome divergence database. BMC Genomics 9: 373.
12. Vissa VD, Brennan PJ, (2001) The genome of Mycobacterium leprae: a minimal mycobacterial gene set. Genome Biol 2: REVIEWS1023.
13. Hsiao WW, Fraser-Liggett CM, (2009) Human Microbiome Project-paving the way to a better understanding of ourselves and our microbes. Drug Discov Today 14: 331-333.
14. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, et al. (2007) The human microbiome project. Nature 449: 804-810.
15. Anishetty S, Pulimi M, Pennathur G, (2005) Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Comput Biol Chem 29: 368-378.
16. Hasan S, Daugelat S, Rao PS, Schreiber M, (2006) Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. PLoS Comput Biol 2: e61.
17. Raman K, Yeturu K, Chandra N, (2008) targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol 2: 109.
18. Kinnings SL, Xie L, Fung KH, Jackson RM, Bourne PE, (2010) The Mycobacterium tuberculosis drugome and its polypharmacological implications. PLoS Comput Biol 6: e1000976.
19. Anurag M, Dash D, (2009) Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis. Mol Biosyst 5: 1752-1757.
20. Cheng Y, LeGall T, Oldfield CJ, Mueller JP, Van YY, et al. (2006) Rational drug design via intrinsically disordered protein. Trends Biotechnol 24: 435-442.
21. Kojima K, Konopleva M, McQueen T, O'Brien S, Plunkett W, et al. (2006) Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia. Blood 108: 993-1000.
22. Lindsay MA, (2003) Target discovery. Nat Rev Drug Discov 2: 831-838.
23. Knowles J, Gromo G, (2003) A guide to drug discovery: Target selection in drug discovery. Nat Rev Drug Discov 2: 63-69.
24. Sampson SL, (2011) Mycobacterial PE/PPE proteins at the host-pathogen interface. Clin Dev Immunol.
25. Alber T, (2009) Signaling mechanisms of the Mycobacterium tuberculosis receptor Ser/Thr protein kinases. Curr Opin Struct Biol 19: 650-657.
26. Wehenkel A, Bellinzoni M, Grana M, Duran R, Villarino A, et al. (2008) Mycobacterial Ser/Thr protein kinases and phosphatases: physiological roles and therapeutic potential. Biochim Biophys Acta 1784: 193-202.
27. Babushok DV, Ostertag EM, Kazazian HH Jr, (2007) Current topics in genome evolution: molecular mechanisms of new gene formation. Cell Mol Life Sci 64: 542-554.
28. Chothia C, Gough J, Vogel C, Teichmann SA, (2003) Evolution of the protein repertoire. Science 300: 1701-1703.
29. Yang S, Doolittle RF, Bourne PE, (2005) Phylogeny determined by protein domain content. Proc Natl Acad Sci U S A 102: 373-378.
30. Finn RD, Mistry J, Tate J, Coggill P, Heger A, et al. (2010) The Pfam protein families database. Nucleic Acids Res 38: D211-222.
31. Tompa P, Fuxreiter M, Oldfield CJ, Simon I, Dunker AK, et al. (2009) Close encounters of the third kind: disordered domains and the interactions of proteins. Bioessays 31: 328-335.
32. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, et al. (2001) Intrinsically disordered protein. J Mol Graph Model 19: 26-59.
33. Tompa P, (2002) Intrinsically unstructured proteins. Trends Biochem Sci 27: 527-533.
34. Dyson HJ, Wright PE, (2002) Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol 12: 54-60.
35. He B, Wang K, Liu Y, Xue B, Uversky VN, et al. (2009) Predicting intrinsic disorder in proteins: an overview. Cell Res 19: 929-949.
36. Dosztányi Z, Mészáros B, Simon I, (2010) Bioinformatical approaches to characterize intrinsically disordered/unstructured proteins. Brief Bioinform 11: 225-243.
37. Mészáros B, Simon I, Dosztányi Z, (2009) Prediction of protein binding regions in disordered proteins. PLoS Comput Biol 5: e1000376.
38. Romero P, Obradovic Z, Li X, Garner EC, Brown CJ, et al. (2001) Sequence complexity of disordered protein. Proteins 42: 38-48.
39. Dosztányi Z, Csizmók V, Tompa P, Simon I, (2005) The pairwise energy content estimated from amino acid composition discriminates between folded and intrinsically unstructured proteins. J Mol Biol 347: 827-839.
40. Dosztányi Z, Csizmók V, Tompa P, Simon I, (2005) IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics 21: 3433-3434.
41. Dosztányi Z, Mészáros B, Simon I, (2009) ANCHOR: web server for predicting protein binding regions in disordered proteins. Bioinformatics 25: 2745-2746.
42. Lew JM, Kapopoulou A, Jones LM, Cole ST, (2010) TubercuList- 10 years after. Tuberculosis (Edinb) 91: 1-7.
43. Guell M, van Noort V, Yus E, Chen WH, Leigh-Bell J, et al. (2009) Transcriptome complexity in a genome-reduced bacterium. Science 326: 1268-1271.
44. Yus E, Maier T, Michalodimitrakis K, van Noort V, Yamada T, et al. (2009) Impact of genome reduction on bacterial metabolism and its regulation. Science 326: 1263-1268.
45. Kuhner S, van Noort V, Betts MJ, Leo-Macias A, Batisse C, et al. (2009) Proteome organization in a genome-reduced bacterium. Science 326: 1235-1240.
46. Takayama K, Wang C, Besra GS, (2005) Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev 18: 81-101.
47. Glazko GV, Mushegian AR, (2004) Detection of evolutionarily stable fragments of cellular pathways by hierarchical clustering of phyletic patterns. Genome Biol 5: R32.
48. Kim Y, Subramaniam S, (2006) Locally defined protein phylogenetic profiles reveal previously missed protein interactions and functional relationships. Proteins 62: 1115-1124.
49. Kim Y, Koyuturk M, Topkara U, Grama A, Subramaniam S, (2006) Inferring functional information from domain co-evolution. Bioinformatics 22: 40-49.
50. Av-Gay Y, Everett M, (2000) The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis. Trends Microbiol 8: 238-244.
51. Yeats C, Finn RD, Bateman A, (2002) The PASTA domain: a beta-lactam-binding domain. Trends Biochem Sci 27: 438.
52. Barthe P, Mukamolova GV, Roumestand C, Cohen-Gonsaud M, (2010) The structure of PknB extracellular PASTA domain from mycobacterium tuberculosis suggests a ligand-dependent kinase activation. Structure 18: 606-615.
53. Dasgupta A, Datta P, Kundu M, Basu J, (2006) The serine/threonine kinase PknB of Mycobacterium tuberculosis phosphorylates PBPA, a penicillin-binding protein required for cell division. Microbiology 152: 493-504.
54. Good MC, Greenstein AE, Young TA, Ng HL, Alber T, (2004) Sensor domain of the Mycobacterium tuberculosis receptor Ser/Thr protein kinase, PknD, forms a highly symmetric beta propeller. J Mol Biol 339: 459-469.
55. Scherr N, Honnappa S, Kunz G, Mueller P, Jayachandran R, et al. (2007) Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 104: 12151-12156.
56. D'Andrea LD, Regan L, (2003) TPR proteins: the versatile helix. Trends Biochem Sci 28: 655-662.
57. Scherr N, Muller P, Perisa D, Combaluzier B, Jeno P, et al. (2009) Survival of pathogenic mycobacteria in macrophages is mediated through autophosphorylation of protein kinase G. J Bacteriol 191: 4546-4554.
58. Thakur M, Chaba R, Mondal AK, Chakraborti PK, (2008) Interdomain interaction reconstitutes the functionality of PknA, a eukaryotic type Ser/Thr kinase from Mycobacterium tuberculosis. J Biol Chem 283: 8023-8033.
59. Grundner C, Gay LM, Alber T, (2005) Mycobacterium tuberculosis serine/threonine kinases PknB, PknD, PknE, and PknF phosphorylate multiple FHA domains. Protein Sci 14: 1918-1921.
60. Jayakumar D, Jacobs WR Jr, Narayanan S, (2008) Protein kinase E of Mycobacterium tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infection. Cell Microbiol 10: 365-374.
61. Deol P, Vohra R, Saini AK, Singh A, Chandra H, et al. (2005) Role of Mycobacterium tuberculosis Ser/Thr kinase PknF: implications in glucose transport and cell division. J Bacteriol 187: 3415-3420.
62. Sharma K, Gupta M, Pathak M, Gupta N, Koul A, et al. (2006) Transcriptional control of the mycobacterial embCAB operon by PknH through a regulatory protein, EmbR, in vivo. J Bacteriol 188: 2936-2944.
63. Gopalaswamy R, Narayanan S, Chen B, Jacobs WR, Av-Gay Y, (2009) The serine/threonine protein kinase PknI controls the growth of Mycobacterium tuberculosis upon infection. FEMS Microbiol Lett 295: 23-29.
64. Canova MJ, Veyron-Churlet R, Zanella-Cleon I, Cohen-Gonsaud M, Cozzone AJ, et al. (2008) The Mycobacterium tuberculosis serine/threonine kinase PknL phosphorylates Rv2175c: mass spectrometric profiling of the activation loop phosphorylation sites and their role in the recruitment of Rv2175c. Proteomics 8: 521-533.
65. Kumar P, Kumar D, Parikh A, Rananaware D, Gupta M, et al. (2009) The Mycobacterium tuberculosis protein kinase K modulates activation of transcription from the promoter of mycobacterial monooxygenase operon through phosphorylation of the transcriptional regulator VirS. J Biol Chem 284: 11090-11099.
66. Brennan MJ, Delogu G, (2002) The PE multigene family: a 'molecular mantra' for mycobacteria. Trends Microbiol 10: 246-249.
67. Banu S, Honore N, Saint-Joanis B, Philpott D, Prevost MC, et al. (2002) Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol Microbiol 44: 9-19.
68. Gey van Pittius NC, Sampson SL, Lee H, Kim Y, van Helden PD, et al. (2006) Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol Biol 6: 95.
69. Fortune SM, Jaeger A, Sarracino DA, Chase MR, Sassetti CM, et al. (2005) Mutually dependent secretion of proteins required for mycobacterial virulence. Proc Natl Acad Sci U S A 102: 10676-10681.
70. Sassetti CM, Rubin EJ, (2003) Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A 100: 12989-12994.
71. Voskuil MI, Schnappinger D, Rutherford R, Liu Y, Schoolnik GK (2004) Regulation of the Mycobacterium tuberculosis PE/PPE genes. Tuberculosis (Edinb) 84: 256-262.
72. Tundup S, Pathak N, Ramanadham M, Mukhopadhyay S, Murthy KJ, et al. (2008) The co-operonic PE25/PPE41 protein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune response. PLoS One 3: e3586.
73. Strong M, Sawaya MR, Wang S, Phillips M, Cascio D, et al. (2006) Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103: 8060-8065.
74. Parra M, Pickett T, Delogu G, Dheenadhayalan V, Debrie AS, et al. (2004) The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis. Infect Immun 72: 6799-6805.
75. Chakhaiyar P, Nagalakshmi Y, Aruna B, Murthy KJ, Katoch VM, et al. (2004) Regions of high antigenicity within the hypothetical PPE major polymorphic tandem repeat open-reading frame, Rv2608, show a differential humoral response and a low T cell response in various categories of patients with tuberculosis. J Infect Dis 190: 1237-1244.
76. Kruh NA, Troudt J, Izzo A, Prenni J, Dobos KM, (2010) Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. PLoS One 5: e13938.
77. Cohen P, (2002) Protein kinases-the major drug targets of the twenty-first century? Nat Rev Drug Discov 1: 309-315.
78. Wehenkel A, Fernandez P, Bellinzoni M, Catherinot V, Barilone N, et al. (2006) The structure of PknB in complex with mitoxantrone, an ATP-competitive inhibitor, suggests a mode of protein kinase regulation in mycobacteria. FEBS Lett 580: 3018-3022.
79. Young TA, Delagoutte B, Endrizzi JA, Falick AM, Alber T, (2003) Structure of Mycobacterium tuberculosis PknB supports a universal activation mechanism for Ser/Thr protein kinases. Nat Struct Biol 10: 168-174.
80. Udell CM, Rajakulendran T, Sicheri F, Therrien M, (2011) Mechanistic principles of RAF kinase signaling. Cell Mol Life Sci 68: 553-565.
81. Lemmon MA, Schlessinger J, (2010) Cell signaling by receptor tyrosine kinases. Cell 141: 1117-1134.
82. Gay LM, Ng HL, Alber T, (2006) A conserved dimer and global conformational changes in the structure of apo-PknE Ser/Thr protein kinase from Mycobacterium tuberculosis. J Mol Biol 360: 409-420.
83. Fedorov O, Marsden B, Pogacic V, Rellos P, Muller S, et al. (2007) A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc Natl Acad Sci U S A 104: 20523-20528.
84. Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, et al. (2008) A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26: 127-132.
85. Wells JA, McClendon CL, (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450: 1001-1009.
86. Ollis DL, Cheah E, Cygler M, Dijkstra B, Frolow F, et al. (1992) The alpha/beta hydrolase fold. Protein Eng 5: 197-211.
87. Tallaksen-Greene SJ, Kaatz KW, Romano C, Albin RL, (1998) Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res 780: 210-217.
88. Cheng Y, LeGall T, Oldfield CJ, Mueller JP, Van Y-YJ, et al. (2006) Rational drug design via intrinsically disordered protein. Trends Biotechnol 24: 435-442.
89. Metallo SJ, (2010) Intrinsically disordered proteins are potential drug targets. Curr Opin Chem Biol 14: 481-488.
90. Dyson HJ, Wright PE, (2005) Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6: 197-208.
91. Dunker AK, Uversky VN, (2010) Drugs for 'protein clouds': targeting intrinsically disordered transcription factors. Curr Opin Pharmacol 10: 782-788.
92. Jones DT, (1999) Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 292: 195-202.
93. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K, (2002) Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43: 717-731.
94. Cho SH, Goodlett D, Franzblau S, (2006) ICAT-based comparative proteomic analysis of non-replicating persistent Mycobacterium tuberculosis. Tuberculosis (Edinb) 86: 445-460.
95. Rosenkrands I, Slayden RA, Crawford J, Aagaard C, Barry CE, et al. (2002) Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J Bacteriol 184: 3485-3491.
96. Voskuil MI, Visconti KC, Schoolnik GK (2004) Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb) 84: 218-227.
97. Chao J, Wong D, Zheng X, Poirier V, Bach H, et al. (2010) Protein kinase and phosphatase signaling in Mycobacterium tuberculosis physiology and pathogenesis. Biochim Biophys Acta 1804: 620-627.
98. Csermely P, Ágoston V, Pongor S, (2005) The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 26: 178-182.
99. van Wageningen S, Kemmeren P, Lijnzaad P, Margaritis T, Benschop JJ, et al. (2010) Functional overlap and regulatory links shape genetic interactions between signaling pathways. Cell 143: 991-1004.
100. UniProt Consortium (2010) The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res 38: D142-148.
101. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.